Agios Pharmaceuticals annual gross margin
2016
2017
2018
2019
2022
2023
2024
2025
Agios Pharmaceuticals Gross Margin Growth & History (AGIO)
Agios Pharmaceuticals's gross margin was 88.26% for fiscal 2025.
View full Agios Pharmaceuticals company overviewAgios Pharmaceuticals annual gross margin history
| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | 88.26% | −0.33 pp |
| 2024 | 2024-12-31 | 88.59% | −0.67 pp |
| 2023 | 2023-12-31 | 89.26% | +1.23 pp |
| 2022 | 2022-12-31 | 88.03% | — |
| 2019 | 2019-12-31 | 98.88% | +0.36 pp |
| 2018 | 2018-12-31 | 98.52% | −1.48 pp |
| 2017 | 2017-12-31 | 100.00% | 0.00 pp |
| 2016 | 2016-12-31 | 100.00% | — |
Agios Pharmaceuticals quarterly gross margin
Q3.17
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | 93.30% | +6.97 pp |
| Q1 2026 | 2026-03-31 | 93.64% | +6.08 pp |
| Q4 2025 | 2025-12-31 | 90.59% | +2.33 pp |
| Q3 2025 | 2025-09-30 | 86.96% | −4.30 pp |
| Q2 2025 | 2025-06-30 | 86.33% | +3.69 pp |
| Q1 2025 | 2025-03-31 | 87.57% | −4.78 pp |
| Q4 2024 | 2024-12-31 | 88.26% | −3.49 pp |
| Q3 2024 | 2024-09-30 | 91.27% | −0.18 pp |
| Q2 2024 | 2024-06-30 | 82.65% | −0.85 pp |
| Q1 2024 | 2024-03-31 | 92.34% | +2.22 pp |
| Q4 2023 | 2023-12-31 | 91.75% | +1.33 pp |
| Q3 2023 | 2023-09-30 | 91.44% | +6.15 pp |
| Q2 2023 | 2023-06-30 | 83.49% | −8.71 pp |
| Q1 2023 | 2023-03-31 | 90.12% | +30.87 pp |
| Q4 2022 | 2022-12-31 | 90.42% | — |
| Q3 2022 | 2022-09-30 | 85.30% | — |
| Q2 2022 | 2022-06-30 | 92.21% | — |
| Q1 2022 | 2022-03-31 | 59.25% | — |
| Q4 2020 | 2020-12-31 | −357.15% | −456.34 pp |
| Q3 2020 | 2020-09-30 | 98.16% | −0.33 pp |
| Q2 2020 | 2020-06-30 | 98.19% | −0.65 pp |
| Q1 2020 | 2020-03-31 | 99.39% | +0.49 pp |
| Q4 2019 | 2019-12-31 | 99.19% | +1.53 pp |
| Q3 2019 | 2019-09-30 | 98.49% | +3.06 pp |
| Q2 2019 | 2019-06-30 | 98.84% | −1.16 pp |
| Q1 2019 | 2019-03-31 | 98.90% | −1.10 pp |
| Q4 2018 | 2018-12-31 | 97.66% | — |
| Q3 2018 | 2018-09-30 | 95.43% | −4.57 pp |
| Q2 2018 | 2018-06-30 | 100.00% | — |
| Q1 2018 | 2018-03-31 | 100.00% | — |
| Q3 2017 | 2017-09-30 | 100.00% | — |
Agios Pharmaceuticals gross margin trends
Between the periods ended 2016-12-31 and 2025-12-31, Agios Pharmaceuticals's gross margin decreased from 100.00% to 88.26%, a change of −11.74 percentage points. The latest reported quarter, Q2 2026, shows 93.30%.
About the metric
What gross margin means
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
Calculation and source
How gross margin is calculated
TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Agios Pharmaceuticals source filings ↗